Viking Therapeutics Inc [NASDAQ: VKTX] surged by $3.79 during the normal trading session on while it closed the day at $68.86. Viking Therapeutics Inc stock has also gained 6.48% of its value over the past 7 days. However, VKTX stock has inclined by 220.13% in
Viking Therapeutics Inc [NASDAQ: VKTX] loss -2.71% on the last trading session, reaching $64.67 price per share at the time. If compared to the average trading volume of 6.46M shares, VKTX reached a trading volume of 2382538 in the most recent trading day, which is
Viking Therapeutics Inc [NASDAQ: VKTX] loss -6.07% on the last trading session, reaching $73.68 price per share at the time. The company report on March 26, 2024 at 7:03 AM that Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of
Viking Therapeutics Inc [NASDAQ: VKTX] gained 16.82% on the last trading session, reaching $80.83 price per share at the time. If compared to the average trading volume of 6.11M shares, VKTX reached a trading volume of 19447830 in the most recent trading day, which is
Viking Therapeutics Inc [NASDAQ: VKTX] gained 2.89% on the last trading session, reaching $65.18 price per share at the time. The company report on March 4, 2024 at 4:45 PM that Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of
Viking Therapeutics Inc [NASDAQ: VKTX] traded at a low on Monday, posting a -11.62 loss after which it closed the day’ session at $63.44. The company report on March 4, 2024 at 4:45 PM that Viking Therapeutics Announces Closing of Public Offering of Common Stock
Viking Therapeutics Inc [NASDAQ: VKTX] gained 10.60% on the last trading session, reaching $85.22 price per share at the time. The company report on February 28, 2024 at 8:50 PM that Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock. Viking Therapeutics,
Viking Therapeutics Inc [NASDAQ: VKTX] stock went on an upward path that rose over 121.02% on Tuesday, amounting to a one-week price increase of more than 137.97%. The company report on February 27, 2024 at 4:19 PM that Viking Therapeutics Announces Proposed Public Offering of
Viking Therapeutics Inc [NASDAQ: VKTX] jumped around 1.63 points on Wednesday, while shares priced at $32.23 at the close of the session, up 5.33%. The company report on February 7, 2024 at 4:05 PM that Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
Viking Therapeutics Inc [NASDAQ: VKTX] traded at a high on Thursday, posting a 18.01 gain after which it closed the day’ session at $28.89. The company report on February 7, 2024 at 4:05 PM that Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
© 2024, Powered by Smart TechOne
